Literature DB >> 19913620

Functional expression of single-chain Fv antibody in the cytoplasm of Escherichia coli by thioredoxin fusion and co-expression of molecular chaperones.

Hiroyuki Sonoda1, Yoichi Kumada, Tomohisa Katsuda, Hideki Yamaji.   

Abstract

The production of a single-chain variable fragment (scFv) antibody against bovine ribonuclease A in the cytoplasm of Escherichia coli trxB/gor double mutant was investigated. Previous reports have shown that the thioredoxin (Trx) protein fusion strategy is useful for the correct folding of scFvs and that the expression of functional scFvs is increased by co-expression of molecular chaperones. In the present study, we examined the effects of the combination of Trx fusion and molecular chaperone co-expression on the production of a functional scFv. A Trx-fused scFv was obtained in the oxidizing cytoplasm, and co-expression of GroELS and trigger factor had the greatest effect, resulting in a 2.8-fold increase in specific productivity. By contrast, the molecular chaperone DnaKJE had no effect. Moreover, co-expression of DnaKJE with GroELS negated the effects of GroELS. Trx-scFv was purified using a bovine ribonuclease A-coupled Sepharose column, and 2.7 mg/L of purified protein was obtained. Soluble Trx-scFv, expressed and purified as described above, exhibited pH-dependent binding similar to that of the parental full-length antibody. In addition, approximately 80% of the initial binding activity was retained after incubation at 37 degrees C for 2 weeks, indicating that the Trx-scFv fusion protein is quite stable. This strategy might be useful for the preparation of other recombinant scFvs. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913620     DOI: 10.1016/j.pep.2009.11.003

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  The 3D protein of duck hepatitis A virus type 1 binds to a viral genomic 3' UTR and shows RNA-dependent RNA polymerase activity.

Authors:  Yu Zhang; Qianda Cao; Mingshu Wang; Renyong Jia; Shun Chen; Dekang Zhu; Mafeng Liu; Kunfeng Sun; Qiao Yang; Ying Wu; Xinxin Zhao; Xiaoyue Chen; Anchun Cheng
Journal:  Virus Genes       Date:  2017-06-09       Impact factor: 2.332

Review 3.  Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.

Authors:  Hendrik Waegeman; Wim Soetaert
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-08       Impact factor: 3.346

4.  Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.

Authors:  Ondřej Kaplan; Jana Zárubová; Barbora Mikulová; Elena Filová; Jiřina Bártová; Lucie Bačáková; Eduard Brynda
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

5.  Soluble Expression of Humanized Anti-CD20 Single Chain Antibody in Escherichia coli by Cytoplasmic Chaperones Co-expression.

Authors:  Mohammadreza Yousefi; Safar Farajnia; Ahad Mokhtarzadeh; Bahman Akbari; Shiva Ahdi Khosroshahi; Mina Mamipour; Hassan Dariushnejad; Vahideh Ahmadzadeh
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jul-Sep

Review 6.  Design and Production of Bispecific Antibodies.

Authors:  Qiong Wang; Yiqun Chen; Jaeyoung Park; Xiao Liu; Yifeng Hu; Tiexin Wang; Kevin McFarland; Michael J Betenbaugh
Journal:  Antibodies (Basel)       Date:  2019-08-02

7.  Efficient expression of EpEX in the cytoplasm of Escherichia coli using thioredoxin fusion protein.

Authors:  Farideh Rasooli; Atieh Hashemi
Journal:  Res Pharm Sci       Date:  2019-12-11

8.  High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli.

Authors:  Kristof Zarschler; Stefanie Witecy; Franz Kapplusch; Christian Foerster; Holger Stephan
Journal:  Microb Cell Fact       Date:  2013-10-27       Impact factor: 5.328

9.  Novel bifunctional single-chain variable antibody fragments to enhance virolysis by complement: generation and proof-of-concept.

Authors:  Georg Huber; Zoltán Bánki; Renate Kunert; Heribert Stoiber
Journal:  Biomed Res Int       Date:  2014-01-12       Impact factor: 3.411

Review 10.  Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments.

Authors:  Annamaria Sandomenico; Jwala P Sivaccumar; Menotti Ruvo
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.